Viridian Therapeutics, Inc.\DE VRDN 24.32
Health Care · NASDAQ · Data as of 2026-08-06
Viridian Therapeutics, Inc.\DE (VRDN) has delivered -5.4% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1948 of 1968 stocks overall and #257 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
24.32
Overall Rank
#1948 / 1968
Sector Rank
#257 / 260
Revenue CAGR
-5.4%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio